NEW YORK and LONDON, Jan. 11, 2021 (GLOBE NEWSWIRE) -- Tiziana Life Sciences plc (NASDAQ: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today announced that it is participating in the J.P. Morgan 39th Annual Healthcare Conference 2021.

View post:
Tiziana Life Sciences to participate at J.P. Morgan Healthcare Conference 2021

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh